Search 

Meet The Science Behind at the UK Pavilion, booth 38.
The Science Behind Limited specialises in delivering cutting-edge neuroscience technologies and capabilities tailored for early-phase clinical trials focused on neurodegenerative diseases and central nervous system disorders. Our team develops multimodal solutions, integrated into complex clinical trial designs to cost-effectively leverage central nervous system measures, and provide unparalleled objective insights into physiological responses to drug effects.

Meet TheraCryf at the UK Pavilion, booth 38.

TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative therapeutics in oncology and behavioural brain disorders. TheraCryf’s strategy is to generate compelling data sets with a goal of partnering its programmes with mid-size to large pharma.

Formerly Evgen Pharma plc, the Company acquired Chronos Therapeutics in April 2024.  TheraCryf, the new name for the Group, reflects a wider mission and broader portfolio.  The Company’s clinical asset is SFX-01, a patented sulforaphane-based medicine. Chronos’ neuropsychiatry assets use novel chemistry to address highly relevant targets in brain health and have composition of matter patent cover.  The Group Company has the expertise to develop and commercialise the combined portfolio.

Meet Trinova Life at the UK Pavilion, booth 38.
Wherever you are along the path of commercialisation, Trinova Life is here to help accelerate your progress - providing support to build and grow, secure investment and partnerships, and fulfill your vision of bringing impactful innovation to the world.